Introduction
Intracranial aneurysms are characterized by abnormal focal dilation of the intracranial arterial wall and affect approximately 3.2% of the general population worldwide.1 Rupture results in aneurysmal subarachnoid hemorrhage,2 which remains associated with substantial mortality and long-term morbidity.3,4 Over the past three decades, endovascular treatment has become a major therapeutic strategy for both ruptured and unruptured aneurysms, supported by landmark randomized and long-term follow-up data.4,5 Coiling, flow diversion, stent assistance, balloon remodeling, and other adjunctive techniques have expanded the range of aneurysms that can be treated endovascularly, although risks such as incomplete occlusion, recurrence, intraoperative rupture, and thromboembolic events remain clinically important.6-9
For many years, transfemoral access (TFA) served as the default access route for neurointerventional procedures because the femoral artery provides a relatively large caliber and stable catheter support. However, femoral access is associated with puncture-site complications, including hematoma, pseudoaneurysm, and arteriovenous fistula.10,11 Retroperitoneal hemorrhage is less common but potentially serious,12,13 and femoral access generally requires a period of postprocedural immobilization.10 These disadvantages are especially relevant in elderly patients, patients receiving antithrombotic therapy, and patients with unfavorable groin anatomy.
Transradial access (TRA) was first established in cardiovascular intervention and has subsequently expanded into neurointerventional practice.14-18 Potential advantages include superficial compressibility of the radial artery, early ambulation, improved patient comfort, and reduced severe access-site bleeding. TRA introduces specific technical challenges, including smaller vessel caliber, radial artery spasm, and subclavian tortuosity.19,20 Transition to a radial-first practice also requires appropriate access selection and preservation of TFA proficiency.21 A learning curve and radial artery loops represent additional technical considerations.22,23 Ulnar artery access has been explored as an additional upper-extremity option,24,25 while distal radial access has also been evaluated in neurointerventional and cardiovascular practice.26,27 These approaches require careful patient selection and should not be generalized beyond the available evidence.
Evidence regarding TRA and TFA spans several levels of directness. Randomized evidence comparing access routes is currently available for diagnostic cerebral angiography, not for intracranial aneurysm embolization.19 Aneurysm-specific evidence remains sparse and primarily observational.28,29 Mixed neurointerventional studies provide useful access-safety and therapeutic feasibility context,20,30,31 while health-economic analyses provide additional information on recovery and resource use.32 These findings should not be treated as direct evidence for intracranial aneurysm embolization. Dedicated devices, including radial-specific guiding systems and large-bore support catheters, may expand the feasibility of TRA in selected complex procedures.28,33 This review therefore discusses TRA as a complementary access option for selected patients and experienced operators, while emphasizing that TFA remains necessary in many clinical scenarios (Table 1).19,20,28-32
| Study / Source | Procedure context | Design | Evidence relevance | Key access-related finding | How it should be interpreted |
|---|
| Bhatia et al.19 | Diagnostic cerebral angiography | Randomized clinical trial | Diagnostic angiography; indirect background evidence | Reported similar procedural success for TRA and TFA in diagnostic angiography | Useful for access feasibility, but not direct evidence for aneurysm embolization |
| Rentiya et al.20 | Cerebral angiography and mixed neurointerventional procedures | Systematic review and meta-analysis | Mixed neurointervention; indirect for aneurysm embolization | Supports overall feasibility of TRA across mixed neurointerventional practice | Heterogeneous source data; should not be read as aneurysm-specific proof |
| Hanaoka et al.28 | Anterior circulation intracranial aneurysm coiling | Observational clinical series | Direct aneurysm embolization evidence | Radial-first aneurysm coiling with a radial-specific guiding sheath was reported feasible in selected patients | Non-randomized experience; patient anatomy and operator expertise are central |
| Fuga et al.29 | Endovascular treatment of unruptured intracranial aneurysms | Comparative observational study | Direct aneurysm embolization evidence | Reported therapeutic efficacy and complication profiles for radial versus femoral access | Directly relevant, but still observational and potentially affected by selection bias |
| Catapano et al.31 | Mixed neuroendovascular procedures | Propensity-adjusted cohort | Therapeutic neurointervention; indirect for aneurysm embolization | Provides comparative access-site complication data after adjustment | Not aneurysm-specific; useful mainly for access-safety context |
| Khanna et al.30 | Acute stroke interventions | Comparative cohort | Acute stroke intervention; indirect therapeutic evidence | Shows experience with TRA in therapeutic neurointervention outside aneurysm coiling | Clinical transferability to aneurysm embolization is limited |
| Catapano et al.32 | Mixed neuroendovascular procedures | Propensity-adjusted cost analysis | Health-economic evidence; indirect | Suggests radial access may influence costs through access-site complications and recovery pathway | Cost conclusions are healthcare-system dependent and not aneurysm-specific |
This narrative review aims to summarize current direct and indirect evidence comparing TRA and TFA for intracranial aneurysm embolization, with emphasis on technical feasibility, access-related complications, patient selection, device considerations, clinical outcomes, cost considerations, and remaining evidence gaps.
This review was informed by targeted searches of PubMed, Embase, the Cochrane Library, and Web of Science Core Collection, supplemented by manual review of relevant reference lists. Priority was given to studies addressing intracranial aneurysm embolization, neurointerventional access-route outcomes, and foundational cardiovascular access evidence where it clarified mechanisms or patient-centered outcomes. Selected foundational papers outside the main contemporary search window were retained when they provided important context. Because this is a narrative review rather than a systematic review, evidence was synthesized descriptively, with emphasis on study design, procedural context, and directness to intracranial aneurysm embolization. In keeping with this narrative design, no protocol registration, predefined eligibility criteria, or formal risk-of-bias assessment was undertaken; this descriptive approach distinguishes the present review from a systematic review or meta-analysis, a point readers should bear in mind when interpreting its conclusions.
Learning curve, anatomical indications, and device development
Learning curve and training challenges
TRA for neurointerventional procedures, including intracranial aneurysm embolization, is characterized by a distinct learning curve, requiring operators to develop proficiency in navigating complex vascular anatomy and in catheter manipulation techniques. Safe navigation of the full catheter pathway—from the radial artery through the brachial and subclavian arteries and the aortic arch to the internal carotid or vertebral artery—while accommodating individual anatomical variation is a core prerequisite for minimizing procedural complications.18
Available learning-curve data are derived mainly from diagnostic cerebral angiography. These studies indicate that technical efficiency improves with operator experience, although the number of procedures required to achieve proficiency varies among operators and may be influenced by prior endovascular experience.22 These findings remain indirect for aneurysm embolization, which typically involves more complex device handling and intracranial navigation. During early TRA adoption, attention to fluoroscopy efficiency and radiation exposure remains important. A phased progression from simpler to more complex cases is a reasonable training approach, although the optimal training paradigm for aneurysm embolization has not been established.
Transition from TFA to TRA requires adaptation to upper-extremity and aortic arch anatomy, catheter formation, and device manipulation.18 Learning-curve data further indicate that technical efficiency improves with operator experience.22 Structured training and phased case selection may therefore facilitate the safe integration of TRA into aneurysm embolization practice.
Anatomical indications and patient selection
Patient selection for TRA in intracranial aneurysm embolization is a key determinant of procedural success, influenced by anatomical conditions and underlying disease status. Not all patients are suitable TRA candidates. The Allen test, with objective modifications such as the Barbeau test, may be used to assess palmar collateral circulation. However, the Allen test has limited predictive value for ischemic hand events and should not be used as an absolute determinant of TRA eligibility.18 Collateral-circulation assessment may instead be considered as one component of preprocedural evaluation. Other factors that may argue against TRA or require particular caution include prior radial artery harvest, severe upper-extremity vessel tortuosity or occlusion, and device requirements that are incompatible with radial access. However, with the development of small-diameter dedicated devices, the TRA-eligible population is gradually expanding.28
Aortic arch and supra-aortic vessel morphology influence TRA feasibility. Acute target-vessel takeoff angles and other unfavorable proximal vascular features may increase technical difficulty,35 whereas a bovine arch is not uniformly unfavorable and may facilitate catheterization of some left-sided targets.18 Access suitability should therefore be individualized according to the target vessel, laterality, and patient anatomy.
Notably, TRA may also provide access to posterior-circulation targets through the vertebral artery in selected cases; however, evidence specific to intracranial aneurysm embolization remains limited.37
Therefore, comprehensive preoperative imaging evaluation of vascular anatomy is an essential prerequisite for optimal access selection. Clinical decision-making requires balanced consideration of procedural feasibility, device requirements, and individual patient benefit to maximize procedural success and minimize complications (Fig. 1).
Technological innovation of dedicated devices
Radial-specific guiding sheaths and large-bore support catheters may improve catheter support in selected procedures.28,33 Radial compression protocols are used to achieve hemostasis after TRA.10 Flow diversion and other adjunctive endovascular techniques have expanded treatment options for complex intracranial aneurysms.38-40 Complex aneurysm treatments may still require greater device support, so access-route compatibility should be assessed individually.33 Device innovation should be viewed as expanding options, not eliminating the need for TFA.
Limitations, controversies, and future perspectives
Limitations and controversies of existing evidence
The evidence base for comparing TRA and TFA in intracranial aneurysm embolization has substantial methodological limitations. No randomized trial has directly compared the two access routes specifically for aneurysm treatment; the available randomized evidence concerns diagnostic cerebral angiography.19 Most aneurysm-specific evidence is retrospective and single-center,28,29 making it susceptible to selection bias; anatomical factors are also known to affect TRA feasibility.35 Operator experience is another major confounder, as TRA outcomes are often reported by centers with specific expertise. This review draws on three levels of evidence: direct aneurysm-embolization studies, indirect therapeutic neurointerventional evidence, and diagnostic/cardiovascular background evidence. Readers should interpret claims according to this hierarchy. Future multicenter studies should report standardized access conversion, puncture-site complications, radiation exposure, patient-reported outcomes, angiographic durability, and long-term neurological outcomes.
Future research directions and clinical practice recommendations
Future research should prioritize prospective multicenter studies with clearly defined safety endpoints, including severe access-site complications, symptomatic stroke, procedure conversion, and all-cause mortality. Secondary endpoints should include procedure duration, radiation exposure, patient comfort, length of stay, cost, aneurysm occlusion, retreatment, and functional outcome. Standardized reporting of radial artery occlusion, spasm, pseudoaneurysm, and failed access attempts is needed. Practical clinical algorithms should incorporate operator experience, radial artery diameter, collateral-circulation assessment when clinically appropriate, arch anatomy, aneurysm complexity, and device-profile requirements. Until stronger evidence becomes available, TRA should be selected through individualized and shared decision-making with patients; TFA should remain readily available when anatomy, urgency, or device requirements favor femoral access.
Declarations
Acknowledgments
AI-assisted language tools (specifically, Grammarly and ChatGPT-4) were used for grammar checking, sentence structure refinement, and language polishing only. These tools were not used for literature search, data analysis, evidence grading, clinical interpretation, or generation of original scientific content. All literature review, evidence summary, critical analysis, clinical judgment, and substantive revisions were performed independently by the authors. The final manuscript represents the authors’ own intellectual work, and the authors take full responsibility for all content.
Funding
This research was supported by the Concept Validation Fund of Guangdong Medical Association (GNYZ-0005). The funding source had no role in review design, literature search, evidence synthesis, decision to publish, or manuscript preparation.
Conflict of interest
Dr. Waisang Poon has served as Editor-in-Chief of Neurosurgical Subspecialties since July 2024. The authors declare no other conflicts of interest.
Author contributions
Literature review, evidence summary (XY, WY), study conception and design (XY, WY, WH, CH, WP), interpretation of findings (WP), manuscript drafting, and critical revision (XY, WY, WH, CH, WP). All authors approved the final manuscript.